Globally, breast cancer is one of the most prevalent diseases, inducing critical intimidation to human health. Lipid-based nanomaterials have been successfully demonstrated as drug carriers for breast cancer treatment. To date, the development of a better drug delivery system based on lipid nanomaterials is still urgent to make the treatment and diagnosis easily accessible to breast cancer patients. In a drug delivery system, lipid nanomaterials have revealed distinctive features, including high biocompatibility and efficient drug delivery. Specifically, a targeted drug delivery system based on lipid nanomaterials has inherited the advantage of optimum dosage and low side effects. In this review, insights on currently used potential lipid-based nanomaterials are collected and introduced. The review sheds light on conjugation, targeting, diagnosis, treatment, and clinical significance of lipid-based nanomaterials to treat breast cancer. Furthermore, a brighter side of lipid-based nanomaterials as future potential drug delivery systems for breast cancer therapy is discussed.

Original languageEnglish
Article number2948
Issue number17
Publication statusPublished - Sept 2022


  • breast cancer
  • conjugation
  • drug delivery system
  • efficacy
  • exosomes
  • liposomes
  • micelles
  • safety
  • targeting

ASJC Scopus subject areas

  • General Chemical Engineering
  • General Materials Science


Dive into the research topics of 'Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy'. Together they form a unique fingerprint.

Cite this